Developmental methamphetamine exposure results in short- and long-term alterations in hypothalamic-pituitary-adrenal-axis-associated proteins

Developmental Neuroscience

Volumn 35, Issue 4, 2013, Pages 338-346

  Zuloaga, Damian G ^a   Siegel, Jessica A ^a   Acevedo, Summer F ^a   Agam, Maayan ^b   Raber, Jacob ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Departments of Neurology   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Behavioral and cognitive deficits; Hypothalamic pituitary adrenal axis associated proteins; Methamphetamine exposure

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; METHAMPHETAMINE; OXYTOCIN; VASOPRESSIN; HYPOTHALAMIC PITUITARY ADRENAL AXIS ASSOCIATED PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EXPOSURE; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; BEHAVIOR DISORDER; CENTRAL NUCLEUS (AMYGDALA); COGNITION; COGNITIVE DEFECT; CONFOCAL MICROSCOPY; DENTATE GYRUS; IMMUNOHISTOCHEMISTRY; MOOD; SUPRACHIASMATIC NUCLEUS; SUPRAOPTIC NUCLEUS;

ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORTICOSTERONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOHISTOCHEMISTRY; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; TISSUE FIXATION; VASOPRESSINS;

EID: 84883455407     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000351278     Document Type: Article

References (57)

1. Substance Abuse and Mental Health Services Administration (SAMHSA): Results from the 2009 National Survey on Drug Use and Health. Rockville, Office of Applied Studies, SAMHSA, 2010, vol 1: Summary of National Findings.
2. Piper B, Acevedo SF, Kolchugina GK, Butler RW, Corbett SM, Honeycutt EB, Craytor MJ, Raber J: Abnormalities in parentally rated executive function in methamphetamine/polysubstance exposed children. Pharmacol Biochem Behav 2011; 98: 432-439.
3. Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, Ernst T: Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 2004; 132: 95-106.
4. LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C, Arria A, Huestis MA, Della- Grotta S, Lin H, Dansereau LM, Lester BM: Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics 2012; 129: 681-688.
5. Acevedo SF, Pfankuch T, van Meer P, Raber J: Role of histamine in short- and long-term effects of methamphetamine on the developing mouse brain. J Neurochem 2008; 107: 976-986.
6. Williams MT, Inman-Wood SL, Morford LL, McCrea AE, Ruttle AM, Moran MS, Rock SL, Vorhees CV: Preweaning treatment with methamphetamine induces increases in both corticosterone and ACTH in rats. Neurotoxicol Teratol 2000; 22: 751-759.
7. Grace CE, Schaefer TL, Herring NR, Skelton MR, McCrea AE, Vorhees CV, Williams MT: (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats. Synapse 2008; 62: 110-121.
8. Zhu H, Mingler MK, McBride ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Williams MT, Vorhees CV, Rothenberg ME: Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1. Psychoneuroendocrinology 2010; 35: 1119-1132.
9. Soderpalm A, Nikolayev L, de Wit H: Effects of stress on responses to methamphetamine in humans. Psychopharmacology (Berl) 2003; 170: 188-199.
10. Nagano M, Ozawa H, Suzuki H: Prenatal dexamethasone exposure affects anxiety-like behaviour and neuroendocrine systems in an age-dependent manner. Neurosci Res 2008; 60: 364-371.
11. Brabham T, Phelka A, Zimmer C, Nash A, Lopez JF, Vazquez DM: Effects of prenatal dexamethasone on spatial learning and response to stress is influenced by maternal factors. Am J Physiol Regul Integr Comp Physiol 2000; 279:R1899-R1909.
12. Noorlander CW, Visser GH, Ramakers GM, Nikkels PG, de Graan PN: Prenatal corticosteroid exposure affects hippocampal plasticity and reduces lifespan. Dev Neurobiol 2008; 68: 237-246.
13. Zuloaga DG, Carbone DL, Hiroi R, Chong DL, Handa RJ: Dexamethasone induces apoptosis in the developing rat amygdala in an age-, region-, and sex-specific manner. Neuroscience 2011; 199: 535-547.
14. Zuloaga DG, Carbone DL, Quihuis AM, Hiroi R, Chong DL, Handa RJ: Perinatal dexamethasone- induced alterations in apoptosis within the hippocampus and paraventricular nucleus of the hypothalamus are influenced by age and sex. J Neurosci Res 2012; 90: 1403-1412.
15. Fukumoto K, Morita T, Mayanagi T, Tanokashira D, Yoshida T, Sakai A, Sobue K: Detrimental effects of glucocorticoids on neuronal migration during brain development. Mol Psychiatry 2009; 14: 1119-1131.
16. Rugerio-Vargas C, Ramirez-Escoto M, DelaRosa- Rugerio C, Rivas-Manzano P: Prenatal corticosterone influences the trajectory of neuronal development, delaying or accelerating aspects of the Purkinje cell differentiation. Histol Histopathol 2007; 22: 963-969.
17. Banjanin S, Kapoor A, Matthews SG: Prenatal glucocorticoid exposure alters hypothalamicpituitary- adrenal function and blood pressure in mature male guinea pigs. J Physiol 2004; 558: 305-318.
18. Shoener JA, Baig R, Page KC: Prenatal exposure to dexamethasone alters hippocampal drive on hypothalamic-pituitary-adrenal axis activity in adult male rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: 1366-1373.
19. Dean F, Matthews SG: Maternal dexamethasone treatment in late gestation alters glucocorticoid and mineralocorticoid receptor mRNA in the fetal guinea pig brain. Brain Res 1999; 846: 253-259.
20. Tsuda MC, Yamaguchi N, Ogawa S: Early life stress disrupts peripubertal development of aggression in male mice. Neuroreport 2011; 22: 259-263.
21. Matthews SG, Owen D, Banjanin S, Andrews MH: Glucocorticoids, hypothalamo-pituitary- adrenal (HPA) development, and life after birth. Endocr Res 2002; 28: 709-718.
22. Jones RA: Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study. 1. Neurologic, psychological, and educational outcomes. Pediatrics 2005; 116: 370-378.
23. Spijker AT, van Rossum EF: Glucocorticoid receptor polymorphisms in major depression. Focus on glucocorticoid sensitivity and neurocognitive functioning. Ann NY Acad Sci 2009; 1179: 199-215.
24. Egashira N, Mishima K, Iwasaki K, Oishi R, Fujiwara M: New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions. J Pharmacol Sci 2009; 109: 44-49.
25. Kovacs GL, Bohus B, Versteeg DH, de Kloet ER, de Wied D: Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures. Brain Res 1979; 175: 303-314.
26. King G, Alicata D, Cloak C, Chang L: Psychiatric symptoms and HPA axis function in adolescent methamphetamine users. J Neuroimmune Pharmacol 2010; 5: 582-591.
27. Siegel JA, Park BS, Raber J: Long-term effects of neonatal methamphetamine exposure on cognitive function in adolescent mice. Behav Brain Res 2011; 219: 159-164.
28. Altman J, Bayer SA: Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods. J Comp Neurol 1990; 301: 365-381.
29. Clancy B, Darlington RB, Finlay BL: Translating developmental time across mammalian species. Neuroscience 2001; 105: 7-17.
30. Williams MT, Blankenmeyer TL, Schaefer TL, Brown CA, Gudelsky GA, Vorhees CV: Longterm effects of neonatal methamphetamine exposure in rats on spatial learning in the Barnes maze and on cliff avoidance, corticosterone release, and neurotoxicity in adulthood. Brain Res Dev Brain Res 2003; 147: 163-175.
31. Siegel JA, Craytor MJ, Raber J: Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in mice. Behav Pharmacol 2010; 21: 602-614.
32. Acevedo SF, de Esch IJ, Raber J: Sex- and histamine- dependent long-term cognitive effects of methamphetamine exposure. Neuropsychopharmacology 2007; 32: 665-672.
33. Eastwood E, Allen CN, Raber J: Effects of neonatal methamphetamine and thioperamide exposure on spatial memory retention and circadian activity later in life. Behav Brain Res 2012; 230: 229-236.
34. Kitraki E, Kremmyda O, Youlatos D, Alexis MN, Kittas C: Gender-dependent alterations in corticosteroid receptor status and spatial performance following 21 days of restraint stress. Neuroscience 2004; 125: 47-55.
35. Kitraki E, Kremmyda O, Youlatos D, Alexis M, Kittas C: Spatial performance and corticosteroid receptor status in the 21-day restraint stress paradigm. Ann NY Acad Sci 2004; 1018: 323-327.
36. Zhe D, Fang H, Yuxiu S: Expressions of hippocampal mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) in the single- prolonged stress-rats. Acta Histochem Cytochem 2008; 41: 89-95.
37. Rood BD, De Vries GJ: Vasopressin innervation of the mouse (Mus musculus) brain and spinal cord. J Comp Neurol 2011; 519: 2434- 2474.
38. Rood BD, Stott RT, You S, Smith CJ, Woodbury ME, de Vries GJ: Site of origin of and sex differences in the vasopressin innervation of the mouse (Mus musculus) brain. J Comp Neurol 2013; 521: 2321-2358.
39. Krisch B: Electron microscopic immunocytochemical investigation on the postnatal development of the vasopressin system in the rat. Cell Tissue Res 1980; 205: 453-471.
40. Liu HL, Cao R, Jin L, Chen LW: Immunocytochemical localization of substance P receptor in hypothalamic oxytocin-containing neurons of C57 mice. Brain Res 2002; 948: 175-179.
41. Swaab DF, Pool CW, Nijveldt F: Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophypopseal system. J Neural Transm 1975; 36: 195-215.
42. Nishi M, Usuku T, Itose M, Fujikawa K, Hosokawa K, Matsuda KI, Kawata M: Direct visualization of glucocorticoid receptor positive cells in the hippocampal regions using green fluorescent protein transgenic mice. Neuroscience 2007; 146: 1555-1560.
43. Schmidt MV, Oitzl MS, Muller MB, Ohl F, Wurst W, Holsboer F, Levine S, De Kloet ER: Regulation of the developing hypothalamicpituitary- adrenal axis in corticotropin releasing hormone receptor 1-deficient mice. Neuroscience 2003; 119: 589-595.
44. Dyball RE, Koizumi K: Electrical activity in the supraoptic and paraventricular nuclei associated with neurohypophysial hormone release. J Physiol 1969; 201: 711-722.
45. Roozendaal B, McGaugh JL: Amygdaloid nuclei lesions differentially affect glucocorticoid- induced memory enhancement in an inhibitory avoidance task. Neurobiol Learn Mem 1996; 65: 1-8.
46. Kuhn CM, Pauk J, Schanberg SM: Endocrine responses to mother-infant separation in developing rats. Dev Psychobiol 1990; 23: 395- 410.
47. Krasnova IN, Cadet JL: Methamphetamine toxicity and messengers of death. Brain Res Rev 1999; 60: 379-407.
48. Deng X, Wang Y, Chou J, Cadet JL: Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res Mol Brain Res 2001; 93: 64-69.
49. Uht RM, McKelvy JF, Harrison RW, Bohn MC: Demonstration of glucocorticoid receptor- like immunoreactivity in glucocorticoidsensitive vasopressin and corticotropin-releasing factor neurons in the hypothalamic paraventricular nucleus. J Neurosci Res 1988; 19: 405-411, 468-469.
50. de Souza LM, Franci CR: Differential immunoreactivity of glucocorticoid receptors and vasopressin in neurons of the anterior and medial parvocellular subdivisions of the hypothalamic paraventricular nucleus. Brain Res Bull 2010; 82: 271-278.
51. van Tol HH, Snijdewint FG, Boer GJ, Burbach JP: Postnatal development of vasopressin mRNA content in supraoptic and paraventricular nucleus of the Wistar rat. Neurosci Lett 1986; 65: 1-6.
52. Sloboda DM, Newnham JP, Challis JR: Effects of repeated maternal betamethasone administration on growth and hypothalamic-pituitary- adrenal function of the ovine fetus at term. J Endocrinol 2000; 165: 79-91.
53. Pan Y, Liu Y, Young KA, Zhang Z, Wang Z: Post-weaning social isolation alters anxietyrelated behavior and neurochemical gene expression in the brain of male prairie voles. Neurosci Lett 2009; 454: 67-71.
54. Kabbaj M, Yoshida S, Numachi Y, Matsuoka H, Devine DP, Sato M: Methamphetamine differentially regulates hippocampal glucocorticoid and mineralocorticoid receptor mRNAs in Fischer and Lewis rats. Brain Res Mol Brain Res 2003; 117: 8-14.
55. Lowy MT, Novotney S: Methamphetamineinduced decrease in neural glucocorticoid receptors: relationship to monoamine levels. Brain Res 1994; 638: 175-181.
56. Vorhees CV, Skelton MR, Grace CE, Schaefer TL, Graham DL, Braun AA, Williams MT: Effects of (+)-methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats. Int J Dev Neurosci 2009; 27: 289-298.
57. Deng X, Wang Y, Chou J, Cadet JL: Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res Mol Brain Res 2001; 93: 64-69.